Literature DB >> 30639281

Chronic CaMKII inhibition reverses cardiac function and cardiac reserve in HF mice.

Qianwen He1, Jun Cheng2, Yanggan Wang3.   

Abstract

AIMS: The present study was to explore the impact of KN93 - a specific inhibitor of CaMKII - on cardiac function and cardiac reserve in HF mice. MAIN
METHODS: We have generated pressure-overload HF mice using modified transverse aortic constriction (TAC) method. For acute inhibition (AI) experiment, HF mice were randomly divided into HF group, HF + KN93 AI group and HF + KN92 AI group, using sham mice as control. Mice in HF + KN93 AI group and HF + KN92 AI group were injected with CaMKII inhibitor KN93 or its inactive analogue KN92 on post-TAC day 15, while mice in HF group and Sham group were treated with saline. For chronic inhibition (CI) experiment, mice were injected daily with KN93, KN92 or saline for one week. At baseline and after isoproterenol (Iso) injection, in vivo cardiac function was assessed by echocardiography and left ventricular pressure-volume catheter. KEY
FINDINGS: Acute inhibition of CaMKII leads to decreased -dP/dtmin, increased EF, FS, longitudinal strain, longitudinal strain rate, ESPVR, dP/dtmax-EDV, PRSW, Tau and EDPVR, and unaltered reactivity to Iso in HF mice. Chronic inhibition results in increased EF, FS, longitudinal strain, longitudinal strain rate, ESPVR, dP/dtmax-EDV and PRSW, without alteration in -dP/dtmin, Tau and EDPVR. In addition, chronic inhibition reverses the effect of Iso on HF mice. SIGNIFICANCE: Although acute CaMKII inhibition can repair systolic function in HF mice, it also exacerbates the diastolic function, whereas chronic inhibition improves both systolic function and cardiac reserve to β-adrenergic stimulation without impairing diastolic function.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CaMKII; Cardiac function; Heart failure; β(1)-AR

Mesh:

Substances:

Year:  2019        PMID: 30639281     DOI: 10.1016/j.lfs.2019.01.010

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  9 in total

1.  Ca2+/Calmodulin-Dependent Protein Kinase II Regulation by RIPK3 Alleviates Necroptosis in Transverse Arch Constriction-Induced Heart Failure.

Authors:  Ji Cao; Jingjing Zhang; Jianan Qian; Xue Wang; Wei Zhang; Xiangfan Chen
Journal:  Front Cardiovasc Med       Date:  2022-04-28

Review 2.  Non-canonical WNT signalling in cardiovascular disease: mechanisms and therapeutic implications.

Authors:  Ioannis Akoumianakis; Murray Polkinghorne; Charalambos Antoniades
Journal:  Nat Rev Cardiol       Date:  2022-06-13       Impact factor: 49.421

3.  A combined CaMKII inhibition and mineralocorticoid receptor antagonism via eplerenone inhibits functional deterioration in chronic pressure overloaded mice.

Authors:  Helen E Driessen; Magda S Fontes; Leonie van Stuijvenberg; Maike A Brans; Marie-Jose Goumans; Marc A Vos; Toon A van Veen
Journal:  J Cell Mol Med       Date:  2020-06-23       Impact factor: 5.310

4.  CaMKII inhibitor KN-93 impaired angiogenesis and aggravated cardiac remodelling and heart failure via inhibiting NOX2/mtROS/p-VEGFR2 and STAT3 pathways.

Authors:  Yajuan Ni; Jie Deng; Hongyuan Bai; Chang Liu; Xin Liu; Xiaofang Wang
Journal:  J Cell Mol Med       Date:  2021-11-29       Impact factor: 5.310

5.  The mitochondrial signaling peptide MOTS-c improves myocardial performance during exercise training in rats.

Authors:  Jinghan Yuan; Manda Wang; Yanrong Pan; Min Liang; Yu Fu; Yimei Duan; Mi Tang; Ismail Laher; Shunchang Li
Journal:  Sci Rep       Date:  2021-10-11       Impact factor: 4.379

6.  Repeated Yueju, But Not Fluoxetine, Induced Sustained Antidepressant Activity in a Mouse Model of Chronic Learned Helplessness: Involvement of CaMKII Signaling in the Hippocampus.

Authors:  Zhilu Zou; Jiaru Huang; Qingqing Yang; Yuxuan Zhang; Bo Xu; Ping Wang; Gang Chen
Journal:  Evid Based Complement Alternat Med       Date:  2022-02-24       Impact factor: 2.629

7.  Effects and potential mechanism of Ca2+/calmodulin‑dependent protein kinase II pathway inhibitor KN93 on the development of ovarian follicle.

Authors:  Jianjie Yu; Xianguo Xie; Yabo Ma; Yi Yang; Chao Wang; Guoliang Xia; Xiangbin Ding; Xinfeng Liu
Journal:  Int J Mol Med       Date:  2022-08-05       Impact factor: 5.314

8.  Chronic Ca2+/Calmodulin-Dependent Protein Kinase II Inhibition Rescues Advanced Heart Failure.

Authors:  Yixi Liu; Qun Shao; Heng-Jie Cheng; Tiankai Li; Xiaowei Zhang; Michael F Callahan; David Herrington; Dalane Kitzman; David Zhao; Che-Ping Cheng
Journal:  J Pharmacol Exp Ther       Date:  2021-03-15       Impact factor: 4.402

9.  RIPK3-Mediated Necroptosis in Diabetic Cardiomyopathy Requires CaMKII Activation.

Authors:  Yun Chen; Xinshuai Li; Yuyun Hua; Yue Ding; Guoliang Meng; Wei Zhang
Journal:  Oxid Med Cell Longev       Date:  2021-06-07       Impact factor: 6.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.